Dyadic management will be available during these events for one-on-one meetings. Interested parties may request a one-on-one meeting at jlavalley@dyadic.com or contact Dyadic at (561) 743-8333. About ...

Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company focused on the development and commercialization of scalable microbial ...

Upon exercise of the option, Dyadic would receive a milestone payment in the mid-seven figures and Janssen would have the right to add additional non-exclusive targets to the collaboration. Dyadic ...

SmallCaps Daily Sits Down with Joe Hazelton to Discuss Dyadic's Product Strategy, Strategic Partnerships, and Long-Term ...

JUPITER, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: DYAI), d/b/a Dyadic Applied BioSolutions (“Dyadic” or the “Company”), a biotechnology company focused on the development and ...

President & COO Joseph Hazelton indicated that since stepping into the President's role in June 2025, the company has accelerated its transition "from a development stage platform company into a ...

Demonstrated substantial revenue increase for Q3 2024, driven primarily by Dapibus™ license fees and milestone payments. Received $1 million milestone payment for animal-free recombinant albumin ...

Highlights from DYAI's recent company updates on protein expression technology and partnerships Dyadic Applied ...

JUPITER, Fla. and COPENHAGEN, Denmark, March 02, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company ...

JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with ...

Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1705993&tp_key=2267a6328b. An archive of the webcast will be available within 24 hours after completion of ...